Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 13, Issue 6

Abstract

Omeprazole (OPZ) efficiently suppresses acid secretion in the parietal cells of the stomach. It is widely recommended as proton pump inhibitor (PPI) in Egypt. Presence of many products containing omeprazole available in the Egyptian market raises questions of generic substitution and/or therapeutic equivalence. The aim of the study was to compare the pharmacokinetic parameters and relative bioequivalence properties of two oral omeprazole formulations, Gastroloc® and Pepzol® enteric coated capsules, in healthy subjects. A randomized, two-way crossover study was conducted to study the pharmacokinetic parameters of the OPZ products in 24 healthy human volunteers in compliance with the Declaration of Helsinki and ICH guidelines. After oral administration and at specified time intervals, blood samples were collected and analyzed for plasma OPZ content using a validated HPLC method. The Pharmacokinetic parameters such as AUC0-12, Cmax, Tmax, t1/2 and elimination rate constant were determined from plasma concentration-time profile for both formulations by a non-compartmental method. The statistical analysis of the data obtained in this study showed no significant difference between the tested OPZ products. The results indicated that the tested products have similar bioavailability profiles and therefore can be considered bioequivalent based on the obtained data of AUC, Cmax, and Tmax.

Authors and Affiliations

Ehab Ibrahim Taha, Fathy Ibrahim Abd-Alla

Keywords

Related Articles

Development and Validation of First Derivative Spectrophotometric Method for Quantification of Darunavir in Tablets

Aims: Darunavir is widely used in HIV/AIDS therapy. It is a HIV protease inhibitor that has excellent efficacy against the virus. The aim of this study is to develop and validate an analytical method fast and free of int...

Lipid Charecterization and Fatty Acid Profiles of Clarius batrachus and Its Defense Activity

Innate Defense Components were being useful to identify and understand their mode of action on microbial pathogens. The present study portrays the qualitative and quantitative determination of endogenous lipids from the...

Hepatoprotective Activity of Macrotyloma uniflorum (Lam.) Verdc. Seeds Extracts Against Paracetamol Induced Hepatotoxicity in Wistar Albino Rats

Background: Macrotyloma uniflorum (Horse gram) seeds are used in Ayurvedic medicine for treating numerous health disorders including rheumatism, worm, conjunctivitis and piles. The seeds were boiled with water and used a...

Evaluation of Oral Examination of Medical Undergraduates in Pharmacology – A Conceptual Study

Aims: Oral examination has held an important place in medicine for centuries. Apart from some advantages, oral examinations are prone to many errors contributing towards threats to validity like Construct Under-represent...

Development of Validated RP-HPLC Method for Simultanious Estimation of Cefadroxil and Ambroxol in Pure and Pharmaceutical Dosage Form

A precise, accurate, economical and simple HPLC (reverse phase) method was developed for the estimation of Cefadroxil and Ambroxol in bulk and pharmaceutical dosage form. Method was performed on a octadecyl silane column...

Download PDF file
  • EP ID EP342518
  • DOI 10.9734/BJPR/2016/29952
  • Views 65
  • Downloads 0

How To Cite

Ehab Ibrahim Taha, Fathy Ibrahim Abd-Alla (2016). Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products. Journal of Pharmaceutical Research International, 13(6), 1-8. https://europub.co.uk/articles/-A-342518